European Journal of Neurology

Article	Citations
Issue Information	282
	134
Central nervous system crystal‐storing histiocytosis: A case report and literature review	103
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	94
The microbiome–gut–brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications	92
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	92
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	92
Prioritization process for European Academy of Neurology clinical practice guidelines	88
Comparative features and outcomes of major neurological complications of COVID‐19	87
Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study	87
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	86
The risk of worsening of myasthenia by cardiovascular medication as reflected by reporting frequency	82
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	78
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	71
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	68
Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: Identifying relevant outcome factors	62
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis	60
Mirror therapy for unilateral neglect after stroke: A systematic review	58
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	56
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study	56
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	55
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	54
Lessons from the past to understand the future	54
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	53
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	53

Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	52
Immunity and Gilles de la Tourette syndrome: A systematic review and meta‐analysis of evidence for immune implications in Tourette syndrome	49
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	49
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	47
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities	46
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	45
Risk factors, neuroimaging correlates and prognosis of the motoric cognitive risk syndrome: A population‐based comparison with mild cognitive impairment	45
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	43
Long‐term MRI changes in a patient with Kelch‐like protein 11‐associated paraneoplastic neurological syndrome	43
Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications	42
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms	41
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	41
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	41
The effect of influenza vaccination on the rate of dementia amongst older adults	41
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	41
	40
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	40
Oral Presentations	40
Issue Information	39
Issue Information	39
	39
Apolipoprotein E epsilon4 allele is associated with better performance language and visual memory in spinocerebellar ataxia type 3	38
Focused Workshops	38
Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study	38
Neurology Undergraduate Medical Education: A Scoping Review	38
Issue Information	38
Can Non‐Thymomatous Late‐Onset Myasthenia Gravis Benefit From Thymectomy? A Systematic Review and Meta‐Analysis	37
‘Positive’ inter‐ictal clinical signs of functional neurological disorders are found in patients with functional dissociative seizures	36
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response	36
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome	35
SARS‐CoV‐2 cannot unmask Parkinson's disease if there was none before infection	35
A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance	35
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease	35
High‐resolution magnetic resonance imaging of acute intracranial artery thrombus	35
A multimodal, longitudinal study of cognitive heterogeneity in early‐onset Alzheimer's disease	34
Dehydration associates with lower urinary tract symptoms in progressive multiple sclerosis	34
Peripheral neuropathy in ataxia‐telangiectasia: Newly characterized, has potential as a biomarker	34
Hypersomnia in anti‐glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study	34
First‐line steroid treatment for spontaneous intracranial hypotension	33
Contractile properties and magnetic resonance imaging‐assessed fat replacement of muscles in myotonia congenita	33
Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea	32
Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis	32
Association of symptomatic atherosclerotic carotid arteries with plaque areas showing low densities on computed tomographic angiography	32
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis	32
Hyponatremia is associated with unfavorable outcomes after reperfusion treatment in acute ischemic stroke	32
Generative artificial intelligence in neurology: Opportunities and risks	31
Ipsilateral hand impairment predicts long‐term outcome in patients with subacute stroke	31
Dynamic Bayesian networks for stratification of disease progression in amyotrophic lateral sclerosis	31
Care in Europe after presenting to the emergency department with a seizure; position paper and insights from the European Audit of Seizure Management in Hospitals	31
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative study	30

Epilepsy professionals' views on sudden unexpected death in epilepsy counselling: A tale of two countries	30
Macroglossia: A potentially severe complication of late‐onset Pompe disease	30
Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross‐sectional population‐based study	30
Type 2 diabetes mellitus duration and subsequent risk of Alzheimer disease	30
Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics	29
Alterations of Fat and Ketone Body Metabolism in ALS and SMA—A Prospective Observational Study	29
Issue Information	29
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage	29
Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy	29
Etiologic distribution of isolated abducens nerve palsy: Analysis of 807 patients and literature review	28
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy	28
Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis	28
Arterial Stiffness, Central Blood Pressure, and the Risk of Incident Stroke in Hypertensive Adults	28
Exploring the role of attention towards balance in chronic dizziness: Development of the Balance Vigilance Questionnaire	28
The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: An analysis of different subtypes based on high‐resolution imaging	28
Nerve Conduction Study and the Prognosis of Amyotrophic Lateral Sclerosis: Exploration of Additional Neuroelectrophysiological Parameters	28
Intraepineurial Fat Fraction: A Novel MR Neurography‐Based Biomarker in Transthyretin Amyloidosis Polyneuropathy	28
Apolipoprotein E polymorphism ε4‐stratified longitudinal association between daytime naps, sleep apnea and mild cognitive impairment: A prospective cohort study	28
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid	27
A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door‐In‐Door‐Out Times in Thrombectomy Patients: A Retrospective Analysis	27
Clinical manifestations and long‐term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Eu	26
Symposia	26
Trajectories of physical activity after ischaemic stroke: Exploring prediction of change	26
Corrigendum to “Tremor After Solid Organ Transplantation: Results From the TransplantLines Biobank and Cohort Study”	26
Nonamyloidogenic TTR gene variants c.76G>A and c.337‐18G>C are not associated with idiopathic small‐fiber neuropathy	26
Risk and outcomes of COVID‐19 in patients with multiple sclerosis	26
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis	26
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome	25
The core/penumbra model: implications for acute stroke treatment and patient selection in 2021	25
Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: A case–control study	25
Association between COVID‐19 vaccination and myasthenia gravis: A population‐based, nested case–control study	25
Elevated Serum MCP‐2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients	25
ePresentations	25
Dolichoarteriopathies of the extracranial internal carotid artery: The Plaque At RISK study	25
Issue Information	25
Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy	25
Prospective follow‐up study of youth and adults with onset of functional tic‐like behaviours during the COVID‐19 pandemic	25
Circulating choline pathway nutrients and depression after ischemic stroke	25
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses	24
Migraine and atrial fibrillation: a systematic review	24
Double immune reconstitution therapy: Cladribine after alemtuzumab in the treatment of multiple sclerosis	24
Letter to the Editor in response to “Hepatitis E virus and Bell’s palsy”	24
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status	24
Non‐alcoholic fatty liver disease and stroke: A Mendelian randomization study	24
A fast and non‐invasive artificial intelligence olfactory‐like system that aids diagnosis of Parkinson's disease	24
A diagnostic framework to identify vestibular involvement in multi‐sensory neurological disease	24
New cellular imaging‐based method to distinguish the SPG4 subtype of hereditary spastic paraplegia	23
Quantitative proteomic analysis of cerebrospinal fluid from patients with idiopathic facial nerve palsy	23
Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain–gut–microbiome interactions in irritable bowel syndrome: Preliminary findings	23
Smartphone and custom‐made software to assess the effect of botulinum toxin in essential blepharospasm: Initial results	23
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis	23
Key priorities in rare neurological diseases: A statement from the Coordinating Panel on Rare Neurological Diseases of the European Academy of Neurology	23
Meningoencephalitis due to Mycobacterium lentiflavum in an immunocompromised patient: Case report	23
Neurofilament light chain and profilin‐1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen	22
Comment on “Association between depression and motoric cognitive risk syndrome among community‐dwelling older adults in China: A 4‐year prospective cohort study”	22
Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke	22
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study	22
Exercise induced muscle blood flow is decreased in Charcot–Marie–Tooth disease type 1 polyneuropathy: a power Doppler analysis	22
Use of antihypertensive medication and formation of de novo intracranial aneurysms	22
Clinical presentation and neural correlates of stroke‐associated spatial delusions	22
Spontaneous intracranial hypotension — Neurological symptoms, diagnosis, and outcome	22
Long‐term follow‐up of 64 children with classical infantile‐onset Pompe disease since 2004: A French real‐life observational study	22
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosis	22
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database	22
Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition	22
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis	21
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)	21
Confirmed disability progression as a marker of permanent disability in multiple sclerosis	21
Epilepsy Management in Transgender Population: More Research for Better Treatment	21
The many faces of globular glial tauopathy: A clinical and imaging study	21
Latency of poststroke epilepsy can predict drug resistance	21
Socioeconomic status as a risk factor for motoric cognitive risk syndrome in a community‐dwelling population: A longitudinal observational study	21
Mutations in alpha‐B‐crystallin cause autosomal dominant axonal Charcot–Marie–Tooth disease with congenital cataracts	21
Optimal cut‐off value of the modified Toronto Clinical Neuropathy Score in the diagnosis of polyneuropathy	21
Quantification of muscle involvement in familial amyloid polyneuropathy using MRI	21
Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes	21
The spectrum of central nervous system involvement in Whipple's disease	21
Brain Iron Alteration in Pediatric Tourette Syndrome: A Quantitative Susceptibility Mapping Study	21
Plenary Sessions	21
Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation	20

Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight	20
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy	20
Cognitive sequelae of long COVID may not be permanent: A prospective study	20
Antidepressant use and stroke or mortality risk in the elderly	20
Association between choroid plexus volume and cognition in Parkinson disease	20
Hormone therapy and disease activity in Danish women with multiple sclerosis: A population‐based cohort study	20
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review	20
Data‐Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis	20
Rheumatoid meningitis: A systematic review and meta‐analysis	20
Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?	20
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial	20
Intracranial aneurysm wall enhancement as an indicator of instability: a systematic review and meta‐analysis	20
Post‐COVID‐Syndrome Patients Might Overestimate Own Cognitive Impairment	20
Corrigendum	19
Decrement of choroid vascularization during spontaneous migraine attacks: An optical coherence tomography angiography study	19
Aetiology of Acute Respiratory Insufficiency in Patients With Ischaemic Stroke Studied by Chest CT Scan	19
Prolonged venous transit is associated with lower odds of excellent recovery after reperfusion in anterior large‐vessel occlusion stroke	19
Issue Information	19
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FT	19
Special Sessions	19
Special Sessions	19
HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K	19
Midline sacral meningeal cysts: Neurophysiology abnormalities and their correlation with pelvic sensory and visceral symptoms	19
History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts	19
	19
Corrigendum	19
The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies	18
Response to the Letter to the Editor by Arshad and Bronstein “Motion perception in vestibular migraine”	18
Analysis of individual alpha frequency in a large cohort from a tertiary memory center	18
Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations	18
Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis	18
Autoimmune encephalitis: Should we consider third‐line immunotherapies earlier?	18
Charcot–Marie–Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study	18
The Attitude towards Polypills Questionnaire (APPQ): a phase I–III development and validation study in patients with cerebrovascular disease	18
Smartphone‐derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis	18
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis	18
Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report	18
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints	18
Younger adults and endovascular thrombectomy	18
Efficiency of stroke networks for referral of mechanical thrombectomy: The more the better?	18
Parkinson disease following COVID‐19: Report of six cases	18
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization	18
The effect of head‐down tilt in experimental acute ischemic stroke	18
Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response	17
Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients	17
Giancarlo COMI (1947–2024)	17
Sex differences in early‐onset Alzheimer's disease	17
Admission computed tomography radiomic signatures outperform hematoma volume in predicting baseline clinical severity and functional outcome in the ATACH‐2 trial intracerebral hemorrhage population	17
Polygenic risk of Alzheimer's disease in the Faroe Islands	17
Cost‐effectiveness of surgical treatment compared to medical treatment in patients with drug‐refractory epilepsy: A systematic review	17
European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases	17
Early infantile epileptic encephalopathy related to NECAP1: Clinical delineation of the disease and review	17
Bruns' nystagmus revisited: A sign of stroke in patients with the acute vestibular syndrome	17
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia	17
The analgesic effect of electroencephalographic neurofeedback for people with chronic pain: A systematic review and meta‐analysis	17
Cerebral Amyloid Angiopathy‐Related Inflammation in Iatrogenic Cerebral Amyloid Angiopathy	17
Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel	17
Quantitative magnetic resonance neurographic characterization of peripheral nerve involvement in manifest and pre‐ataxic spinocerebellar ataxia type 3	17
Global Temporal Trends and Projections of Stroke Among Women of Childbearing Age: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021	17
Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial	17
Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms	17
Global Health Inequalities in the Burden of Ischemic Stroke From 1990 to 2021	17
Association of short‐term exposure to ambient air pollution with mortality from ischemic and hemorrhagic stroke	17
Time‐dependent impact of type 2 diabetes mellitus on incident prodromal Alzheimer disease: A longitudinal study in 1395 participants	16
Epilepsy Stands Nearby: A Pilot CT Perfusion Study on Post‐Stroke Non‐Convulsive Status Epilepticus	16
Suicide Risk and Associated Factors in Parkinson Disease: A Nationwide Cohort Study	16
Thank You to Our Peer Reviewers in 2024	16
Corrigendum	16
	16
	16
Clinical autonomic nervous system laboratories in Europe	16
Focused Workshops	16
Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts	16
The first European Academy of Neurology (EAN) Science School: shaping the next generation of translational neurologists	16
Clinical outcomes of delayed mechanical thrombectomy: Descriptive analysis and development of a screening tool	16
Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke	16
GLP‐1 Agonists as Potential Neuromodulators in Development of Parkinson's Disease: A Nationwide Cohort Study	16
Symposia	16
Plenary Sessions	16
	16
Atrial fibrillation in young stroke patients: Associated factors and outcomes in a nationwide analysis	16
Topical Symposia	16
Catechol‐O‐methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease	16
White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study	16
The 20th anniversary of the first clinical use of Stalevo®	16
Clot signature in patients with large vessel occlusion stroke and concomitant active cancer	16
Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID‐19	16
	16
Relationship between migraine and epilepsy in a large population‐based cohort: The HUNT Study	16
	16
Nonstenotic intracranial atherosclerosis as an emerging mechanism in cryptogenic cerebral embolism	16
A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps	16
Incidence of Guillain–Barré syndrome following SARS‐CoV‐2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines	15
Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment	15
Impact of relative cerebral blood volume reduction on early neurological improvement in extensive ischemic stroke	15